AMANDA JOHNSON: Open Payments
NPI 1215215009 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 35 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $772 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $312 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $201 |
| Janssen Pharmaceuticals, Inc | 5 | $159 |
| ABBVIE INC. | 5 | $94 |
| Lundbeck LLC | 3 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
Products named: Auvelity, CAPLYTA, SPRAVATO, REXULTI, VRAYLAR, INGREZZA, BOTOX, Zilretta.
Industry payments across VA — which companies pay providers there.
